fda compounding semaglutide warning september 2025 Makers of compounded Wegovy, Ozempic threatened by move Compounded vs. FDA-approved medications: What's

Your provider may recommend temporarily pausing dose escalation, adjusting your maintenance dose, or exploring alternative GLP-1 formulations better suited to your gastrointestinal tolerance

These are less likely to happen when the dose is started low and increased slowly, and they usually get better over time

That's cool, but my body is the least interesting thing about me

A key consideration is that weight regain is common once someone stops a GLP-1

1, 2026, Blue Cross Blue Shield's standard coverage plans for some employers won't pay for some weight loss medications, the company said in a statement

Back Manalac, T (23 Dec 2024) '7 Indications for GLP-1s beyond weight loss', BioSpace